A role for glucagon-like peptide-1 in the central regulation of feeding
暂无分享,去创建一个
D. Smith | P. Lambert | S. Bloom | M. Ghatei | C. Edwards | John P H Wilding | K. Meeran | J. Herbert | S. J. Choi | M. Turton | M. Heath | I. Gunn | G. M. Taylor | J. Herbert | M. D. Turton | D. O'Shea | I. Gunn | S. A. Beak | C. M. B. Edwards | K. Meeran | M. M. Heath | P. D. Lambert | J. P. H. Wilding | D. M. Smith | M. A. Ghatei | S. R Bloom | D. O'shea | D. Smith | S. J. Choi | D. Smith | S. J. Choi | S. Choi | D. Smith | G. Taylor
[1] S. Kalra,et al. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. 1985. , 1985, Obesity research.
[2] R. Devos,et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.
[3] M. Pelleymounter,et al. Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.
[4] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[5] P. Lambert,et al. c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y , 1995, Brain Research.
[6] D. Smith,et al. Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.
[7] D. Smith,et al. The presence of islet amyloid polypeptide/calcitonin gene-related peptide/salmon calcitonin binding sites in the rat nucleus accumbens. , 1994, European journal of pharmacology.
[8] B. Göke,et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. , 1993, The Journal of biological chemistry.
[9] P. Lambert,et al. A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. , 1993, Endocrinology.
[10] P. Lambert,et al. Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. , 1993, Neuroendocrinology.
[11] Fiona J. L. Arnold,et al. Expression of c-fos in regions of the basal limbic forebrain following intra-cerebroventricular corticotropin-releasing factor in unstressed or stressed male rats , 1992, Neuroscience.
[12] M. Ghatei,et al. Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. , 1992, The Journal of endocrinology.
[13] S. Ohashi,et al. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. , 1989, Endocrinology.
[14] S. Bloom,et al. Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus , 1989, Brain Research.
[15] S. Kanse,et al. Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung , 1988, FEBS letters.
[16] T. Curran,et al. Expression of c-fos protein in brain: metabolic mapping at the cellular level. , 1988, Science.
[17] J. Morley. Neuropeptide regulation of appetite and weight. , 1987, Endocrine reviews.
[18] P. Rogers,et al. Behavioural structure and mechanisms of anorexia: Calibration of natural and abnormal inhibition of eating , 1985, Brain Research Bulletin.
[19] H. Chow,et al. p-Chlorophenylalanine and p-chloroamphetamine pretreatment of apomorphine-challenged rats: effects on solitary and social behavior. , 1984, European journal of pharmacology.
[20] G. P. Smith,et al. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. , 1975, Journal of comparative and physiological psychology.